| Literature DB >> 32427039 |
Benjamin Asschenfeldt1,2, Lars Evald2,3, Johan Heiberg1,2, Camilla Salvig1, Leif Østergaard4,2,5, Rikke Beese Dalby6, Simon Fristed Eskildsen4,2, Vibeke Elisabeth Hjortdal1,2.
Abstract
Background Neurodevelopmental impairments are common in survivors of complex congenital heart defects (CHD). We report neuropsychological and brain imaging assessments in adults operated for isolated septal defects. Methods and Results Patients (mean age 25.6 yrs) who underwent childhood surgery for isolated atrial septal defect (n=34) or ventricular septal defect (n=32), and healthy matched peers (n=40), underwent a standard battery of neuropsychological tests and a 3.0T brain magnetic resonance imaging scan. Patient intelligence was affected with lower scores on Full-Scale intelligence quotient (P<0.001), Verbal Comprehension (P<0.001), Perceptual Reasoning (P=0.007), and Working Memory (P<0.001) compared with controls. Also, the CHD group had poorer visuospatial abilities (Immediate Recall, P=0.033; Delayed Recall, P=0.018), verbal memory (Trial 1, P=0.015; Total Learning, P<0.001; Delayed Recall, P=0.007), executive function (Executive Composite Score, P<0.001), and social recognition (Reading the Mind in the Eyes Test, P=0.002) compared with controls. Self-reported levels of executive dysfunction, attention deficits and hyperactivity behavior, and social cognition dysfunction were higher in the CHD group compared with population means and controls. We found similar global and regional morphometric brain volumes and a similar frequency of brain magnetic resonance imaging abnormalities in the 2 groups. The CHD group had a high occurrence of psychiatric disease and a larger need for special teaching during school age. Conclusions Children operated for simple CHD demonstrate poorer neurodevelopmental outcomes in adulthood when compared with healthy controls and expected population means. REGISTRATION URL: https://www.clinicaltrials.gov. Unique identifier: NCT03871881.Entities:
Keywords: atrial septal defect; magnetic resonance imaging; neurodevelopmental outcome; neuropsychology; ventricular septal defect
Mesh:
Year: 2020 PMID: 32427039 PMCID: PMC7428999 DOI: 10.1161/JAHA.120.015843
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Demographics and Clinical Characteristics for CHD and Control Participants
| Variable | CHD (n=66) | Control (n=40) |
|
|---|---|---|---|
| At inclusion | |||
| Age, y | 25.6±5.2 | 25.6±4.7 | 0.961 |
| Height, cm | 170±11 | 175±8 | 0.029 |
| BMI, kg/m2 | 24.4±4.1 | 23.0±3.2 | 0.062 |
| Male [n, (%)] | 20 (30) | 14 (35) | 0.616 |
| Education | |||
| ISCED primary education [n, (%)] | 3 (5) | 0 (0) | 0.171 |
| ISCED secondary education [n, (%)] | 49 (74) | 26 (65) | 0.311 |
| ISCED tertiary education [n, (%)] | 14 (21) | 14 (35) | 0.119 |
| Pedagogical psychological counseling | 10 (15) | 1 (3) | 0.038 |
| Special teaching | 30 (45) | 6 (15) | 0.001 |
| Dyslexia [n, (%)] | 11 (17) | 0 (0) | 0.006 |
| Dyscalculia [n, (%)] | 4 (6) | 1 (3) | 0.353 |
Data are presented as mean±SD or as absolute numbers with relative percentages. BMI indicates body mass index; CHD, congenital heart defect; and ISCED, International Standard Classification of Education 2011.
Received pedagogical psychological counseling during primary or secondary school.
Received special teaching during primary or secondary school.
Perioperative Status for ASD and VSD Participants
| Variable | ASD (n=34) | VSD (n=32) |
|---|---|---|
| Age at diagnosis | 6.5±8.0 | 0.5±1.0 |
| Age at surgery | 7.8±7.7 | 1.7±1.4 |
| Defect size, mm | 16.7±8.8 | 8.1±3.9 |
| Total bypass time, min | 44±20 | 59±20 |
| Cross clamp time, min | 16±9 | 30±13 |
| Hospital stay [days, (min–max)] | 7 (2–11) | 10 (6–27) |
| ICU stay [days, (min–max)] | 1 (1–2) | 1 (1–5) |
| Preoperative catherization [n, (%)] | 8 (24) | 12 (38) |
| Mean pulmonary‐to‐systemic blood flow (Qp/Qs) | 2.7±0.9 | 2.9±1.3 |
| ASD type [n, (%)] | ||
| Primum | 2 (6) | … |
| Secundum | 32 (94) | … |
| ASD closure [n, (%)] | ||
| Direct suture | 17 (50) | … |
| Dacron patch | 13 (38) | … |
| Pericardial patch | 4 (12) | … |
| VSD type [n, (%)] | ||
| Perimembranous | … | 17 (53) |
| Muscular | … | 15 (47) |
| VSD closure [n, (%)] | ||
| Patch | … | 21 (66) |
| Direct suture | … | 11 (34) |
| Pulmonary artery banding [n, (%)] | … | 3 (9) |
| Persisting ductus arteriosus closure | … | 3 (9) |
Data are presented as mean±SD, median with range (min–max) or as absolute numbers with relative percentages. ASD indicates atrial septal defect; ICU, intensive care unit; and VSD, ventricular septal defect.
Medical History for CHD and Control Participants
| Variable | CHD (n=66) | Control (n=40) |
|---|---|---|
| Psychiatric diagnosis | ||
| ≥1 Psychiatric diagnoses [n, (%)] | 22 (33) | 4 (10) |
| ≥2 Psychiatric diagnoses [n, (%)] | 12 (18) | 2 (5) |
| Mental and behavioral disorders due to psychoactive substance use | 1 (2) | 0 (0) |
| Schizophrenia, schizotypal and delusional disorders | 1 (2) | 0 (0) |
| Mood (affective) disorders | 18 (27) | 4 (10) |
| Depression [n, (%)] | 15 (23) | 4 (10) |
| Bipolar affective disorder [n, (%)] | 3 (5) | 0 |
| Neurotic, stress‐related and somatoform disorders | 10 (15) | 0 (0) |
| Obsessive‐compulsive disorder [n, (%)] | 6 (9) | … |
| Anxiety [n, (%)] | 4 (6) | … |
| Behavioral syndromes associated with physiological disturbances and physical factors | 7 (11) | 2 (5) |
| Eating disorders | 3 (5) | 2 (5) |
| Nonorganic sleep disorders | 4 (6) | … |
| Disorders of adult personality and behavior | 3 (5) | 0 (0) |
| Personality disorder | 3 (5) | … |
| Disorders of psychological development | 2 (3) | 0 |
| Infantile autism | 1 (2) | … |
| Asperger's syndrome | 1 (2) | … |
| Behavioral and emotional disorders with onset usually occurring in childhood and adolescence | 8 (12) | 0 (0) |
| ADD or ADHD | 8 (12) | … |
| Somatic history | ||
| Brain infections (meningitis, encephalitis etc.) | 0 (0) | 0 (0) |
| Other brain diseases (neoplasms etc.) | 0 (0) | 0 (0) |
| Previous head trauma | 0 (0) | 0 (0) |
| Epilepsy | 1 (2) | 0 (0) |
| Stroke | 0 (0) | 0 (0) |
Data are presented as absolute numbers with relative percentages. ADD indicates attention deficit disorder; ADHD, attention deficit hyperactivity disorder; and CHD, congenital heart defect.
Diagnosed with a psychiatric disease and received treatment.
Neuropsychological Outcomes for CHD and Control Participants
| Variable | ASD (n=34) | VSD (n=32) | CHD (n=66) | Control (n=40) |
|
|
|
|---|---|---|---|---|---|---|---|
| Mean±SD | |||||||
| Wechsler Adult Intelligence Scale Version IV | |||||||
| Full‐scale IQ | 92.6±13.3 | 95.8±13.5 | 94.2±13.4 | 105.6±12.8 | 0.346 | <0.001 | <0.001 |
| Verbal comprehension (index scores) | 89.9±13.5 | 91.2±13.8 | 90.5±13.6 | 105.0±16.4 | 0.719 | <0.001 | <0.001 |
| Perceptual reasoning (index scores) | 92.8±14.9 | 97.1±16.7 | 94.8±15.8 | 103.0±12.9 | 0.273 | 0.007 | 0.010 |
| Working memory (index scores) | 90.8±11.9 | 94.4±13.7 | 92.5±12.9 | 102.2±14.4 | 0.265 | <0.001 | <0.001 |
| Processing speed (index scores) | 103.7±16.2 | 106.7±16.5 | 105.2±16.3 | 111.7±16.9 | 0.461 | 0.054 | 0.012 |
| Delis‐Kaplan executive function system | |||||||
| Executive Composite score (scaled scores) | 10.3±1.6 | 10.2±2.0 | 10.3±1.8 | 11.8±1.8 | 0.677 | <0.001 | 0.275 |
| Trail making (scaled scores) | 10.4±2.1 | 10.3±2.7 | 10.3±2.4 | 11.6±1.5 | 0.902 | 0.003 | 0.249 |
| Verbal fluency (scaled scores) | 11.3±2.4 | 10.9±3.0 | 11.1±2.7 | 13.0±2.2 | 0.503 | <0.001 | 0.001 |
| Design fluency (scaled scores) | 10.0±2.3 | 10.2±2.1 | 10.1±2.2 | 12.0±2.9 | 0.729 | <0.001 | 0.766 |
| Color‐word interference (scaled scores) | 9.2±2.2 | 9.2±2.3 | 9.2±2.3 | 10.9±2.3 | 0.928 | <0.001 | 0.006 |
| Rey‐Osterreith Complex Figure Test | |||||||
| Copy (impaired, n [%]) | 4 (12) | 9 (29) | 13 (20) | 3 (8) | 0.082 | 0.082 | ‐ |
| Time to copy (sec) | 205.5±60.6 | 225.9±63.4 | 215.1±62.3 | 186.5±71.3 | 0.193 | 0.035 | ‐ |
| Immediate recall (T‐scores) | 38.8±12.1 | 44.4±13.5 | 41.5±13.0 | 46.9±11.9 | 0.084 | 0.033 | <0.001 |
| Delayed recall (T‐scores) | 41.4±9.7 | 44.8±10.0 | 43.0±9.9 | 47.5±8.4 | 0.169 | 0.018 | <0.001 |
| Recognition total correct (impaired, no [%]) | 12 (35) | 12 (39) | 24 (37) | 11 (28) | 0.776 | 0.320 | ‐ |
| Rey Auditory Verbal Learning Test | |||||||
| Trial 1 (T‐scores) | 43.4±9.5 | 43.7±10.4 | 43.5±9.9 | 48.5±10.1 | 0.884 | 0.015 | <0.001 |
| Total learning (T‐scores) | 41.8±10.4 | 41.8±11.2 | 41.8±10.7 | 49.4±9.1 | 0.992 | <0.001 | <0.001 |
| Delayed recall (T‐scores) | 42.0±9.3 | 44.1±10.1 | 43.0±9.7 | 48.2±9.0 | 0.375 | 0.007 | <0.001 |
| Recognition (impaired, n [%]) | 0 (0) | 2 (6) | 2 (3) | 0 (0) | 0.132 | 0.263 | ‐ |
| Reading the Mind in the Eyes Test (T‐scores) | 45.2±9.3 | 45.1±9.8 | 45.2±9.5 | 51.0±6.9 | 0.982 | 0.002 | <0.001 |
| BRIEF‐A self‐report (T‐scores) | 56.0±12.1 | 55.3±13.3 | 55.7±12.6 | 46.8±8.3 | 0.836 | <0.001 | 0.005 |
| BRIEF‐A Informant (T‐scores) | 48.6±10.4 | 49.6±11.9 | 49.1±11.1 | 42.5±6.6 | 0.726 | 0.005 | 0.531 |
| CAARS self‐report (T‐scores) | 55.7±12.8 | 53.5±12.7 | 54.6±12.7 | 44.0±11.1 | 0.473 | <0.001 | 0.004 |
| CAARS Informant (T‐scores) | 48.8±11.2 | 51.1±13.3 | 49.9±12.2 | 45.6±8.2 | 0.474 | 0.178 | 0.942 |
| SRS‐2 self‐report (T‐scores) | 55.9±15.2 | 57.3±14.6 | 56.6±14.8 | 46.5±8.5 | 0.704 | <0.001 | <0.001 |
| SRS‐2 Informant (T‐scores) | 50.2±11.5 | 53.4±14.2 | 51.7±12.8 | 44.5±7.9 | 0.329 | 0.007 | 0.314 |
Data are presented as mean±SD or as absolute numbers with relative percentages. Missing <2% of outcomes except for BRIEF‐A self‐report (CHD: n=63; controls: n=38) and informant report (CHD: n=60; controls: n=33), CAARS self‐report (CHD: n=66; controls: n=39), CAARS informant‐report (CHD: n=61; controls: n=34), SRS‐2 self‐report (CHD: n=66; controls: n=38), SRS‐2 self‐report (CHD: n=60; controls: n=33). Calculated expected population means: RFCT (Immediate Recall raw‐score=24.9±5.2, Delayed Recall raw‐score=25.0±6.7, T‐score=50±10); RAVLT (Trial 1 raw score=7.1±1.7, Total learning raw score=54.9±8.85, Delayed recall raw score=11.9±2.9, T‐score=50±10); Reading the Mind in the Eyes Test (raw score=26.2±3.6, T‐score=50±10); BRIEF‐A (self‐report (GEC) raw score=107.28±22.2, T‐score=51±10, Informant (GEC) raw score=110.41±27.5, T‐score=50±10); CAARS (ADHD‐index=50±10); SRS‐2 (50±10). ASD indicates atrial septal defect; BRIEF‐A, Behavior Rating Inventory of Executive Function–Adult; CAARS, Connors’ Adult ADHD Rating Scales; CHD, congenital heart defect; FDR, false discovery rate; GEC, Global Executive Composite; RAVLT, Rey Auditory Verbal Learning Test; RCFT, Rey‐Osterreith Complex Figure Test; SRS‐2, Social Responsiveness Scale Second Edition; and VSD, ventricular septal defect.
FDR q<0.05.
RCFT copy ≤32=impaired.
RCFT recognition total correct (true positives+true negatives) ≤19=Impaired.
RAVLT recognition (true positives) ≤11=impaired.
BRIEF‐A report the Global Executive Composite T‐score.
CAARS report the ADHD‐index T‐score.
SRS‐2 report the Total T‐score.
Figure 1Extreme scores for CHD and Control Participants. Data are presented as percentages. *P<0.05, **FDR q<0.05. †Wechsler Adult Intelligence Scale Version IV; ‡Delis‐Kaplan Executive Function System; §Rey‐Osterreith Complex Figure Test; ||Rey Auditory Verbal Learning Test; #Reading the Mind in the Eyes Test. CHD indicates congenital heart defect and FDR, false discovery rate.
Global and Regional Brain Volumes for CHD and Control Participants
| Variable | ASD (n=33) | VSD (n=30) | CHD (n=63) | Control (n=38) |
|
|
|---|---|---|---|---|---|---|
| Global | ||||||
| Total intracranial volume, cm3 | 1342.9±126.3 | 1372.2±133.9 | 1357.4±129.7 | 1400.4±141.2 | 0.392 | 0.122 |
| Grey matter, cm3 | 788.3±32.9 | 784.6±49.3 | 786.6±41.2 | 771.7±51.0 | 0.726 | 0.112 |
| White matter, cm3 | 434.6±27.7 | 428.1±26.6 | 431.5±27.2 | 437.8±26.8 | 0.260 | 0.349 |
| Corpus callosum, cm2 | 6.0±1.0 | 6.0±0.7 | 5.9±0.8 | 6.2±0.8 | 0.613 | 0.113 |
| Cerebellum, cm3 | 134.2±8.3 | 135.6±11.1 | 134.9±9.7 | 132.4±8.9 | 0.595 | 0.206 |
| Lobes | ||||||
| Frontal right, cm3 | 212.8±10.3 | 207.1±8.5 | 210.1±9.8 | 208.4±10.2 | 0.020 | 0.404 |
| Frontal left, cm3 | 210.2±9.5 | 204.4±8.8 | 207.4±9.5 | 206.7±9.9 | 0.016 | 0.711 |
| Parietal right, cm3 | 102.7±6.4 | 101.5±5.7 | 102.2±6.0 | 103.8±7.1 | 0.434 | 0.237 |
| Parietal left, cm3 | 101.9±6.0 | 101.3±6.6 | 101.6±6.3 | 101.4±7.3 | 0.682 | 0.850 |
| Temporal right, cm3 | 126.2±4.7 | 126.6±7.9 | 126.4±6.4 | 126.2±5.7 | 0.821 | 0.866 |
| Temporal left, cm3 | 121.0±4.9 | 121.9±6.6 | 121.4±5.8 | 121.1±6.2 | 0.538 | 0.841 |
| Occipital right, cm3 | 56.6±4.3 | 57.8±5.5 | 57.2±4.9 | 54.5±5.5 | 0.330 | 0.012 |
| Occipital left, cm3 | 53.7±4.2 | 53.7±5.7 | 53.7±4.9 | 52.9±4.9 | 0.973 | 0.456 |
| Basal nuclei | ||||||
| Thalami, cm3 | 12.6±1.0 | 12.5±0.8 | 12.6±0.9 | 12.7±0.8 | 0.912 | 0.523 |
| Putamen, cm3 | 10.8±8.5 | 11.1±9.4 | 10.9±9.0 | 10.7±9.7 | 0.218 | 0.177 |
| Nucleus Caudate, cm3 | 11.8±9.6 | 11.7±8.3 | 11.8±0.9 | 11.7±0.9 | 0.535 | 0.551 |
| Limbic lobes | ||||||
| Hippocampi, cm3 | 6.0±0.7 | 5.9±0.5 | 5.9±0.6 | 5.9±0.6 | 0.492 | 0.622 |
| Ventricles | ||||||
| Lateral ventricles, cm3 | 15.3±5.9 | 15.2±6.6 | 15.2±6.2 | 13.6±5.6 | 0.938 | 0.184 |
Data are presented as mean±SD. ASD, atrial septal defect; CHD, congenital heart defect; and VSD, ventricular septal defect.
Structural Magnetic Resonance Imaging Findings for CHD and Control Participants
| Variable | ASD (n=33) | VSD (n=30) | CHD (n=63) | Control (n=38) |
|
|
|---|---|---|---|---|---|---|
| Any abnormality | 7 (21) | 8 (27) | 15 (24) | 11 (29) | 0.612 | 0.567 |
| Acquired focal or multifocal abnormality | 1 (3) | 0 (0) | 1 (2) | 2 (5) | 0.336 | 0.292 |
| Focal infarction | 0 (0) | 0 (0) | 0 (0) | 0 (0) | … | … |
| Focal cortical dysplasia | 0 (0) | 0 (0) | 0 (0) | 1 (3) | … | 0.196 |
| Other | 1 (3) | 0 (0) | 1 (2) | 1 (3) | 0.336 | 0.715 |
| Diffuse abnormality | 3 (9) | 3 (10) | 6 (10) | 4 (11) | 0.902 | 0.870 |
| Generalized abnormality | 0 (0) | 0 (0) | 0 (0) | 0 (0) | … | … |
| Developmental abnormality | 3 (9) | 5 (17) | 8 (13) | 6 (16) | 0.367 | 0.663 |
| Major malformation | 1 (3) | 0 (0) | 1 (2) | 0 (0) | 0.336 | 0.435 |
| Minor malformation | 2 (6) | 5 (17) | 7 (11) | 6 (16) | 0.181 | 0.496 |
| White matter hyperintensities | 0.108 | 0.227 | ||||
| None or a single punctate WMH (≤1) | 19 (58) | 23 (77) | 42 (67) | 29 (76) | ||
| Several punctate WMHs (>1 & ≤20) | 14 (42) | 6 (20) | 20 (32) | 7 (18) | ||
| Many punctate WMHs (>20) | 0 (0) | 1 (3) | 1 (2) | 2 (5) |
Data are presented as absolute numbers with relative percentages (n [%]). ASD indicates atrial septal defect; CHD, congenital heart defect; VSD, ventricular septal defect; and WMHs, white matter hyperintensities.
Any abnormality does not include WMHs.
Other focal or multifocal abnormalities comprise unspecific subcortical hyperintensity and gliotic scar around venule.
Diffuse abnormality is Evans’ Index ≥0.3.
The major malformation is a malformation of corpus callosum.
Minor malformations include developmental venous anomaly, Chiari 1 malformation, arachnoid cysts, empty sella and cavum septi pellucidi with and without cavum vergae.